Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
Description
BACKGROUND: As the COVID-19 pandemic continues to spread, the number of associated deaths continues to increase, especially among those with pre-existing conditions. Azvudine is recommended as a priority treatment for patients with COVID-19, but its
